Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Advanced 3-D X-Ray Imaging Provides Insight into the Progression of Idiopathic Pulmonary Fibrosis

By HospiMedica International staff writers
Posted on 02 May 2016
Researchers have used a novel and advanced 3D Computer Tomography (CT) imaging technique to follow the development of an aggressive deadly lung disease called Idiopathic Pulmonary Fibrosis (IPF).

IPF is currently diagnosed using 2D CT scans or by taking a lung biopsy in hospital for investigation under an optical microscope. More...
The new technique, originally designed for aircraft engineering, is used to carry out 3D scans of lung biopsy samples at a resolution similar to that of an optical microscope.

The team from the UK National Institute for Health Research Southampton Respiratory Biomedical Research Unit (BRU), University of Southampton (Southampton, UK) used CT equipment at the µ-VIS Centre for Computed Tomography (Southampton, UK) to perform the Microfocus CT scans. The scan technique involves rotating the biopsy sample 360 degrees while making numerous 2D images, which are rendered into detailed 3D images.

The results of the research were published in the April 21, 2016, issue of the journal JCI Insight. The incidence of IPF in the UK is increasing by 5% every year. In 2015 more than 5,000 new cases were diagnosed in the UK. One of the symptoms of patients with IPF, an interstitial lung disease, is difficulty breathing. The disease causes inflammation, and scarring of lung tissue, and patients have a life expectancy of between three and five years.

Lead author of the study, Dr. Mark Jones, University of Southampton, said, “Whilst accurate diagnosis of IPF is essential to start the correct treatment, in certain cases this can be extremely challenging to do using the tools currently available. This technology advance is very exciting as for the first time it gives us the chance to view lung biopsy samples in 3D. We think that the new information gained from seeing the lung in 3D has the potential to transform how diseases such as IPF are diagnosed. It will also help to increase our understanding of how these scarring lung diseases develop which we hope will ultimately mean better targeted treatments are developed for every patient.”

Related Links:
UK National Institute for Health Research Southampton Respiratory Biomedical Research Unit (BRU), University of Southamptonµ-VIS Centre for Computed Tomography

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Premium Air-Mattress
MA-51
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.